After administration of the lentivirus into each group for genetic manipulation, the data showed that suppression of MLLT11 and TRIL expression inhibited tumor growth relative to the wild-type control group (LV/sh-MLLT11 and LV/sh-TRIL, Figure 4(g,h)). The gene discussed is MLLT11; the disease is neoplasm.